Fernández-Rivas A, García-Estañ J, Vargas F
Departamento de Bioquímica, Facultad de Medicina de Granada, Spain.
J Hypertens. 1995 Jan;13(1):123-8.
Experimental evidence suggests that endogenous nitric oxide plays an important role in the homeostatic response to an increase in sodium intake. In the present study we evaluated the influence of a high sodium intake (1% NaCl as drinking water) on arterial hypertension induced by long-term (6-7 weeks) inhibition of nitric oxide synthesis [NG-nitro-L-arginine methyl ester (L-NAME), 75 mg/100 ml in the drinking fluid] in rats.
Treatment with L-NAME induced progressive elevations in tail-cuff systolic blood pressure, but there were no differences between rats drinking tap water and rats drinking 1% NaCl. Direct measurement of blood pressure at the end of the treatment confirmed the hypertension and the lack of differences between the two groups treated with L-NAME. Metabolic studies performed at the end of L-NAME treatment showed a reduced glomerular filtration rate and elevated urinary excretion of immunoreactive endothelin in the two hypertensive groups treated with L-NAME. Drinking intake, diuresis and natriuresis were significantly higher only in the L-NAME group drinking 1% NaCl. Both groups treated with L-NAME showed an accelerated and increased diuretic and natriuretic response to an isotonic 0.9% NaCl load (2.5 ml/100 g body weight, intraperitoneally). At the end of the study ventricular hypertrophy was observed in both L-NAME groups.
The present results indicate that the time-dependent elevation in blood pressure produced by long-term inhibition of nitric oxide production is not affected by an increased sodium intake. However, salt supplementation induced the development of a polyuria and polydipsia syndrome in rats treated with L-NAME. The elevated excretion of endothelin in both groups treated with L-NAME suggests the possible participation of endothelin in the development of L-NAME hypertension.
实验证据表明内源性一氧化氮在对钠摄入增加的稳态反应中起重要作用。在本研究中,我们评估了高钠摄入(1%氯化钠作为饮用水)对长期(6 - 7周)抑制一氧化氮合成[NG-硝基-L-精氨酸甲酯(L-NAME),饮水中75毫克/100毫升]诱导的大鼠动脉高血压的影响。
用L-NAME治疗导致尾袖收缩压逐渐升高,但饮用自来水的大鼠和饮用1%氯化钠的大鼠之间没有差异。治疗结束时直接测量血压证实了高血压以及用L-NAME治疗的两组之间没有差异。在L-NAME治疗结束时进行的代谢研究表明,在用L-NAME治疗的两个高血压组中,肾小球滤过率降低,免疫反应性内皮素的尿排泄增加。仅在饮用1%氯化钠的L-NAME组中,饮水量、利尿和利钠作用显著更高。用L-NAME治疗的两组对等渗0.9%氯化钠负荷(2.5毫升/100克体重,腹腔内)均表现出加速和增强的利尿和利钠反应。在研究结束时,两个L-NAME组均观察到心室肥厚。
目前的结果表明,长期抑制一氧化氮产生所导致的血压随时间的升高不受钠摄入增加的影响。然而,补充盐分在接受L-NAME治疗